(Bloomberg) -- Diagnosticos da America SA, a health care provider in Brazil, is considering strategic alternatives for its business including selling a stake or control of the company, according to people familiar to the matter. Most Read from BloombergDonald Trump Loses London Case Against Ex-MI6 Spy Over Kremlin DossierA $560 Billion Property Warning Hits Banks From NY to TokyoQQQ Up in Late Trading as Meta Soars, Apple Falls: Markets WrapApple’s China Slump Deepens Even as Total Sales Grow Ag